BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38278308)

  • 1. Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells.
    Wufuer R; Liu K; Feng J; Wang M; Hu S; Chen F; Lin S; Zhang Y
    Free Radic Biol Med; 2024 Mar; 213():488-511. PubMed ID: 38278308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
    Deng R; Zhu Y; Liu K; Zhang Q; Hu S; Wang M; Zhang Y
    Bioorg Chem; 2024 Apr; 145():107212. PubMed ID: 38377819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
    Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.
    Shi L; Chen ZG; Wu LL; Zheng JJ; Yang JR; Chen XF; Chen ZQ; Liu CL; Chi SY; Zheng JY; Huang HX; Lin XY; Zheng F
    Asian Pac J Cancer Prev; 2014; 15(23):10439-44. PubMed ID: 25556489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells.
    Bu Q; Deng Y; Wang Q; Deng R; Hu S; Pei Z; Zhang Y
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127575. PubMed ID: 37866563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/
    Chen J; Wang M; Xiang Y; Ru X; Ren Y; Liu X; Qiu L; Zhang Y
    Oxid Med Cell Longev; 2020; 2020():5138539. PubMed ID: 32273945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unification of Opposites between Two Antioxidant Transcription Factors Nrf1 and Nrf2 in Mediating Distinct Cellular Responses to the Endoplasmic Reticulum Stressor Tunicamycin.
    Zhu YP; Zheng Z; Hu S; Ru X; Fan Z; Qiu L; Zhang Y
    Antioxidants (Basel); 2019 Dec; 9(1):. PubMed ID: 31861550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells.
    Liu P; Kerins MJ; Tian W; Neupane D; Zhang DD; Ooi A
    J Biol Chem; 2019 Nov; 294(48):18131-18149. PubMed ID: 31628195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
    Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
    J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks.
    Hu S; Feng J; Wang M; Wufuer R; Liu K; Zhang Z; Zhang Y
    Redox Biol; 2022 Nov; 57():102470. PubMed ID: 36174386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT).
    Wufuer R; Fan Z; Yuan J; Zheng Z; Hu S; Sun G; Zhang Y
    Antioxidants (Basel); 2022 Aug; 11(8):. PubMed ID: 36009254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells.
    Jin X; Gong L; Peng Y; Li L; Liu G
    Aging (Albany NY); 2020 Dec; 13(1):364-375. PubMed ID: 33290263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor.
    Qiu L; Wang M; Hu S; Ru X; Ren Y; Zhang Z; Yu S; Zhang Y
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30562963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Response against
    Wufuer R; Fan Z; Liu K; Zhang Y
    Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity.
    Zhang Y; Xiang Y
    Biochem J; 2016 Apr; 473(8):961-1000. PubMed ID: 27060105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
    Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
    Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism and Antagonism of Two Distinct, but Confused, Nrf1 Factors in Integral Regulation of the Nuclear-to-Mitochondrial Respiratory and Antioxidant Transcription Networks.
    Zhang S; Deng Y; Xiang Y; Hu S; Qiu L; Zhang Y
    Oxid Med Cell Longev; 2020; 2020():5097109. PubMed ID: 33376579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Cucci MA; Grattarola M; Dianzani C; Damia G; Ricci F; Roetto A; Trotta F; Barrera G; Pizzimenti S
    Free Radic Biol Med; 2020 Apr; 150():125-135. PubMed ID: 32101771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.